Study of an injection for sleep apnea in people with obesity
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Lungs & breathing clinical trials.
This study tests an investigational injection for obstructive sleep apnea (a condition where breathing stops during sleep) in people who are overweight or have obesity. The treatment may help reduce sleep apnea events and improve sleep quality.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with obstructive sleep apnea (OSA) and your sleep study shows at least 15 breathing pauses per hour.
- You are not using or willing to use a CPAP machine (a mask that helps you breathe at night) and have not used it in the last 4 weeks.
- Your body mass index (BMI) is 28 or higher (you have overweight or obesity).
- Your weight has been stable for the last 3 months (no change of more than 5%).
- You are willing to use effective birth control if you or your partner can become pregnant, and you agree not to donate sperm or eggs during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine given as an injection to help people with obstructive sleep apnea and a high body mass index (BMI). It may reduce breathing pauses during sleep and support weight loss, all while you continue using your CPAP machine.
This study tests an investigational injectable medication (HDM1005) to see if it can improve sleep apnea and help with weight loss in people who are obese and have obstructive sleep apnea but do not use a CPAP machine. The drug is given by injection and compared to a placebo.
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
This study tests a new injectable medicine (NNC0487-0111) to help people lose weight and improve obstructive sleep apnea (a breathing condition during sleep). You must already be using a CPAP machine (positive airway pressure device) for your sleep apnea.
This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.
This trial is testing an investigational medication (GZR18) to help people with obesity and obstructive sleep apnea (a condition where breathing stops during sleep) lose weight. It is given alongside the usual positive airway pressure (PAP) therapy, which helps keep the airway open during sleep. The goal is to see if the drug can improve weight and possibly sleep apnea symptoms.
Hear when a new Obstructive Sleep Apnea, Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.